These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 21729796)

  • 1. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned.
    Carragee EJ; Hurwitz EL; Weiner BK
    Spine J; 2011 Jun; 11(6):471-91. PubMed ID: 21729796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis.
    Fu R; Selph S; McDonagh M; Peterson K; Tiwari A; Chou R; Helfand M
    Ann Intern Med; 2013 Jun; 158(12):890-902. PubMed ID: 23778906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion.
    Rodgers MA; Brown JV; Heirs MK; Higgins JP; Mannion RJ; Simmonds MC; Stewart LA
    BMJ; 2013 Jun; 346():f3981. PubMed ID: 23788229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications with the use of bone morphogenetic protein 2 (BMP-2) in spine surgery.
    Tannoury CA; An HS
    Spine J; 2014 Mar; 14(3):552-9. PubMed ID: 24412416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrograde ejaculation after anterior lumbar interbody fusion using rhBMP-2: a cohort controlled study.
    Carragee EJ; Mitsunaga KA; Hurwitz EL; Scuderi GJ
    Spine J; 2011 Jun; 11(6):511-6. PubMed ID: 21612985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.
    Faundez A; Tournier C; Garcia M; Aunoble S; Le Huec JC
    Int Orthop; 2016 Jun; 40(6):1309-19. PubMed ID: 26961193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrograde ejaculation following single-level anterior lumbar surgery with or without recombinant human bone morphogenetic protein-2 in 5 randomized controlled trials: clinical article.
    Burkus JK; Dryer RF; Peloza JH
    J Neurosurg Spine; 2013 Feb; 18(2):112-21. PubMed ID: 23199378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages.
    Haid RW; Branch CL; Alexander JT; Burkus JK
    Spine J; 2004; 4(5):527-38; discussion 538-9. PubMed ID: 15363423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic protein use in spine surgery in the United States: how have we responded to the warnings?
    Guzman JZ; Merrill RK; Kim JS; Overley SC; Dowdell JE; Somani S; Hecht AC; Cho SK; Qureshi SA
    Spine J; 2017 Sep; 17(9):1247-1254. PubMed ID: 28456674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of transforaminal lumbar interbody fusion outcomes in patients receiving rhBMP-2 versus autograft.
    Khan TR; Pearce KR; McAnany SJ; Peters CM; Gupta MC; Zebala LP
    Spine J; 2018 Mar; 18(3):439-446. PubMed ID: 28822825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
    Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
    Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of recombinant human bone morphogenetic protein-2 for spinal fusion: a meta-analysis of individual-participant data.
    Simmonds MC; Brown JV; Heirs MK; Higgins JP; Mannion RJ; Rodgers MA; Stewart LA
    Ann Intern Med; 2013 Jun; 158(12):877-89. PubMed ID: 23778905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the efficacy and safety of Escherichia coli-derived recombinant human bone morphogenetic protein-2 in transforaminal lumbar interbody fusion to treat degenerative spinal disease: a protocol of prospective, randomized controlled, assessor-blinded, open-label, multicenter trial.
    Choi JY; Park HJ; Park SM; Kang CN; Song KS
    J Orthop Surg Res; 2022 Aug; 17(1):397. PubMed ID: 36045371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human bone morphogenetic protein-2 versus autogenous iliac crest bone graft for lumbar fusion: a meta-analysis of ten randomized controlled trials.
    Chen Z; Ba G; Shen T; Fu Q
    Arch Orthop Trauma Surg; 2012 Dec; 132(12):1725-40. PubMed ID: 22941273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2: a prospective study of complications.
    Malham GM; Parker RM; Ellis NJ; Blecher CM; Chow FY; Claydon MH
    J Neurosurg Spine; 2014 Dec; 21(6):851-60. PubMed ID: 25279655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2.
    Lee DD; Kim JY
    J Orthop Surg Res; 2017 Aug; 12(1):126. PubMed ID: 28841904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhBMP-2-induced radiculitis in patients undergoing transforaminal lumbar interbody fusion: relationship to dose.
    Villavicencio AT; Burneikiene S
    Spine J; 2016 Oct; 16(10):1208-1213. PubMed ID: 27343729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.